About Caloprid 1 mg Tablet
Caloprid is a tablet from Square Pharmaceuticals Ltd., with the generic name Prucalopride Succinate. Prucalopride is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.
There are 4 brands of Prucalopride Succinate listed in Bangladesh. By unit price, Caloprid is among the cheapest of them. The lowest listed price is Caloplax 1 mg Tablet at ৳ 14.00 per unit.
What is Caloprid 1 mg Tablet?
Made by Square Pharmaceuticals Ltd., Caloprid is a tablet whose active ingredient is Prucalopride Succinate. Prucalopride is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief. Its activation produces the release of acetylcholine which is the major excitatory neurotransmitter in the GI tract. The doctor decides the dose and course.
Uses of Caloprid
Prucalopride is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief. Ask your doctor whether it is right for your condition.
How to use Caloprid
Swallow the tablet with water. Caloprid is taken by mouth. Take Caloprid 1 mg tablet exactly as your doctor prescribes. Do not change the dose or stop early without asking your doctor. Complete the course exactly as prescribed.
Side effects of Caloprid
Other adverse reactions have been reported occasionally. The majority of adverse events were mild to moderate in intensity. The adverse reactions occur predominantly at the start of therapy and usually disappear within a few days with continued treatment. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
In case of severe diarrhoea, the efficacy of oral contraceptives may be reduced and the use of an additional contraceptive method is recommended to prevent possible failure of oral contraception. Caution should be exercised when prescribing Prucalopride to patients with severe hepatic impairment (Child-Pugh class C) due to limited data in patients with severe hepatic impairment. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/fetal development, parturition, or postnatal development. Keep out of reach of children.
Frequently asked questions
What does Caloprid treat?
Prucalopride is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief. Ask your doctor whether it is right for your condition.
How is Caloprid used?
Swallow the tablet with water. Caloprid is taken by mouth.
What are the side effects of Caloprid?
Other adverse reactions have been reported occasionally. The majority of adverse events were mild to moderate in intensity.
What is the price of Caloprid?
The listed price is ৳ 14.00.
- Strength
- 1 mg
Price in Bangladesh
৳ 14.00 unit price
Price updated: 18 Nov 2026
Indications
Prucalopride is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.
Pharmacology
Prucalopride acts as a selective stimulator of the 5-HT4 receptors while having no interaction with hERG channel or 5-HT1 receptors which reduces significantly the cardiovascular risk found in other similar drugs. 5-HT4 receptors can be found throughout the gastrointestinal tract primarily in smooth muscle cells, enterochromaffin cells, and myenteric plexus. Its activation produces the release of acetylcholine which is the major excitatory neurotransmitter in the GI tract. Hence, prucalopride stimulates motility by interacting specifically with 5-HT4 receptors in the GI tract which causes a release of acetylcholine and further contraction of the muscle layer of the colon and relaxation of the circular muscle layer leading to the propulsion of luminal content.
Dosage & Administration
Adults: 2 mg once daily with or without food, at any time of the day. Due to the specific mode of action of prucalopride (stimulation of propulsive motility), exceeding the daily dose of 2 mg is not expected to increase efficacy.
Older people: Start with 1 mg once daily; if needed the dose can be increased to 2 mg once daily.
Children: Prucalopride should not be used in children and adolescents younger than 18 years
Interaction
In-vitro data indicate that, Prucalopride has a low interaction potential and therapeutic concentrations of Prucalopride are not expected to affect the CYP-mediated metabolism of co medicated medicinal products. Although Prucalopride may be a weak substrate for P-glycoprotein (P-gp), it is not an inhibitor of P-gp at clinically relevant concentrations.
Ketoconazole (200 mg b.i.d.), a potent inhibitor of CYP3A4 and of P-gp, increased the systemic exposure to prucalopride by approximately 40%. This effect is too small to be clinically relevant. Interactions of similar magnitude may be expected with other potent inhibitors of P-gp such as verapamil, cyclosporine A and quinidine.
Studies in healthy subjects showed that, there were no clinically relevant effects of Prucalopride on the pharmacokinetics of warfarin, digoxin, alcohol, paroxetine or oral contraceptives.
Contraindications
Prucalopride is contraindicated in those people who are hypersensitive to the active substance or to any of the excipients and people with renal impairment requiring dialysis.
Side Effects
The most frequently reported adverse reactions associated with Prucalopride therapy are headache (17.8%) and gastrointestinal symptoms (abdominal pain), nausea and diarrhoea. The adverse reactions occur predominantly at the start of therapy and usually disappear within a few days with continued treatment. Other adverse reactions have been reported occasionally. The majority of adverse events were mild to moderate in intensity.
Pregnancy & Lactation
Prucalopride is not recommended during pregnancy and women of childbearing potential should use effective contraception during treatment. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal/fetal development, parturition, or postnatal development. In the absence of human data, it is not recommended to use Prucalopride during breastfeeding
Precautions & Warnings
- Renal excretion is the main route of elimination of prucalopride. A dose of 1 mg is recommended in subjects with severe renal impairment.
- Caution should be exercised when prescribing Prucalopride to patients with severe hepatic impairment (Child-Pugh class C) due to limited data in patients with severe hepatic impairment.
- In case of severe diarrhoea, the efficacy of oral contraceptives may be reduced and the use of an additional contraceptive method is recommended to prevent possible failure of oral contraception.
- The tablets contain lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.
Overdose Effects
An overdose may result in symptoms resulting from an exaggeration of prucalopride's known pharmacodynamic effects and include headache, nausea and diarrhoea. Specific treatment is not available for Prucalopride overdose. Should an overdose occur, the patient should be treated symptomatically and supportive measures instituted, as required. Extensive fluid loss by diarrhoea or vomiting may require correction of electrolyte disturbances.
Storage Conditions
Store at room temperature, below 30°C. Do not remove desiccant. Dispense in original bottle.
Alternative brands of Prucalopride Succinate
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.